MENU
GNLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Genelux (GNLX) Earnings Date & Reports
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer... Show more
A.I. Advisor
published Earnings
GNLX is expected to report earnings to rise 25.00% to -25 cents per share on November 18
Q3'26
Est.
$-0.25
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.02
The last earnings report on May 07 showed earnings per share of -20 cents, beating the estimate of -20 cents. With 170.28K shares outstanding, the current market capitalization sits at 123.07M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
26
Web
https://www.genelux.com